Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Authors
Keywords
-
Journal
Parkinsons Disease
Volume 2019, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2019-11-24
DOI
10.1155/2019/4951379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson’s Disease
- (2019) Liping Zhang et al. Journal of Parkinsons Disease
- Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway
- (2018) Justine Renaud et al. NEUROBIOLOGY OF AGING
- Diabetes mellitus and Parkinson disease
- (2018) Gennaro Pagano et al. NEUROLOGY
- Association between diabetes and subsequent Parkinson disease
- (2018) Eduardo De Pablo-Fernandez et al. NEUROLOGY
- Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease
- (2018) Peng Feng et al. NEUROPHARMACOLOGY
- Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus
- (2018) Norlinah Mohamed Ibrahim et al. MOVEMENT DISORDERS
- D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
- (2017) Yanwei Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Amyloid precursor protein in pancreatic islets
- (2017) Joshua A Kulas et al. JOURNAL OF ENDOCRINOLOGY
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
- (2017) Marissa Ong et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Increased risk of Parkinson disease with diabetes mellitus in a population-based study
- (2017) Yu-Wan Yang et al. MEDICINE
- Metformin Inhibits the Development of l-DOPA-Induced Dyskinesia in a Murine Model of Parkinson’s Disease
- (2017) Young-Kyoung Ryu et al. MOLECULAR NEUROBIOLOGY
- Glitazone use associated with reduced risk of Parkinson's disease
- (2017) Brage Brakedal et al. MOVEMENT DISORDERS
- Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
- (2017) Nikita Katila et al. NEUROPHARMACOLOGY
- Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin
- (2017) Bindu Chamarthi et al. POSTGRADUATE MEDICINE
- Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus
- (2017) Yi-Chun Kuan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes
- (2017) Idira Obasse et al. Interface Focus
- Is Exenatide a Treatment for Parkinson’s Disease?
- (2017) Dilan Athauda et al. Journal of Parkinsons Disease
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
- (2016) M. Petrou et al. ACADEMIC RADIOLOGY
- Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease
- (2016) Henrik H Hansen et al. BRAIN RESEARCH
- Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells
- (2016) Jaishree Jalewa et al. JOURNAL OF NEUROCHEMISTRY
- Neuroendocrine abnormalities in Parkinson's disease
- (2016) Eduardo De Pablo-Fernández et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Alpha-synuclein structure, functions, and interactions
- (2016) FatemehNouri Emamzadeh Journal of Research in Medical Sciences
- Opening of ATP-sensitive K + (K ATP ) channels enhance hydroxyl radical generation induced by MPP + in rat striatum
- (2016) Toshio Obata et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Risk of Parkinson Disease in Diabetes Mellitus
- (2016) Xuejing Yue et al. MEDICINE
- Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation
- (2016) Milena Pinto et al. Molecular Neurodegeneration
- Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study
- (2016) Per Svenningsson et al. MOVEMENT DISORDERS
- Glycation in Parkinson's disease and Alzheimer's disease
- (2016) Hugo Vicente Miranda et al. MOVEMENT DISORDERS
- A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain
- (2016) Lijun Cao et al. NEUROREPORT
- Dopaminergic drugs in type 2 diabetes and glucose homeostasis
- (2016) Felicitas Lopez Vicchi et al. PHARMACOLOGICAL RESEARCH
- Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson’s disease
- (2016) Istvan Horvath et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin resistance and Parkinson’s disease: A new target for disease modification?
- (2016) D. Athauda et al. PROGRESS IN NEUROBIOLOGY
- Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system
- (2016) Afrah A.K. Ismaiel et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
- (2016) Lingjia Xu et al. Parkinsons Disease
- Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice
- (2016) Giuseppe Perruolo et al. Scientific Reports
- A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease
- (2015) Bingjie Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- 2015 Update on Parkinson disease
- (2015) H. H. FERNANDEZ CLEVELAND CLINIC JOURNAL OF MEDICINE
- Mechanisms of Neurodegeration in Type 2 Diabetes and the Neuroprotective Potential of Dipeptidyl Peptidase 4 Inhibitors
- (2015) E. Matteucci et al. CURRENT MEDICINAL CHEMISTRY
- Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways
- (2015) Rania M. Abdelsalam et al. JOURNAL OF NEUROCHEMISTRY
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2015) A.A. Martinez et al. NEUROBIOLOGY OF DISEASE
- Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice
- (2015) Zhili Ren et al. NEUROPHARMACOLOGY
- Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice
- (2015) R. Khang et al. NEUROSCIENCE
- Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases
- (2015) Sun Ju Chung et al. PARKINSONISM & RELATED DISORDERS
- Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective
- (2015) Francesco Zaccardi et al. POSTGRADUATE MEDICAL JOURNAL
- Low alpha-synuclein levels in the blood are associated with insulin resistance
- (2015) Gerardo Rodriguez-Araujo et al. Scientific Reports
- Peripheral Biomarkers of Parkinson’s Disease Progression and Pioglitazone Effects
- (2015) David K. Simon et al. Journal of Parkinsons Disease
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study
- (2015) Erin D. Roe et al. Journal of Diabetes Research
- Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine
- (2014) Janaína K. Barbiero et al. BEHAVIOURAL BRAIN RESEARCH
- Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?
- (2014) Marcelo Lima et al. CNS & Neurological Disorders-Drug Targets
- Efficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: A randomized open labeled phase IV clinical trial
- (2014) Arijit Ghosh et al. INDIAN JOURNAL OF PHARMACOLOGY
- The serum lipid profile of Parkinson's disease patients: a study from China
- (2014) Xiaoyan Guo et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the αβγ Heterotrimeric Complex
- (2014) Shumei Meng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
- (2014) Augusta Pisanu et al. NEUROBIOLOGY OF DISEASE
- System-based approaches to decode the molecular links in Parkinson's disease and diabetes
- (2014) Jose A. Santiago et al. NEUROBIOLOGY OF DISEASE
- Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
- (2014) S.P. Patil et al. NEUROSCIENCE
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
- (2014) Nicolaas I. Bohnen et al. PARKINSONISM & RELATED DISORDERS
- Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
- (2014) Lin Lu et al. PLoS One
- Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
- (2014) Jose A. Santiago et al. PLoS One
- Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats
- (2014) Michael Ezrokhi et al. Diabetology & Metabolic Syndrome
- PINK1 deficiency in -cells increases basal insulin secretion and improves glucose tolerance in mice
- (2014) E. Deas et al. Open Biology
- Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
- (2014) Abid Oueslati et al. Experimental Neurobiology
- Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice
- (2013) Ling Wang et al. EXPERIMENTAL NEUROLOGY
- Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes
- (2013) DE-WEI SONG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
- (2013) Steven E Kahn et al. LANCET
- KATP channels and islet hormone secretion: new insights and controversies
- (2013) Frances M. Ashcroft et al. Nature Reviews Endocrinology
- The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
- (2013) Marija Dulovic et al. NEUROBIOLOGY OF DISEASE
- Multicentre analysis of 178,992 type 2 diabetes patients revealed better metabolic control despite higher rates of hypertension, stroke, dementia and repeated inpatient care in patients with comorbid Parkinson's disease
- (2013) Nicole Scheuing et al. PARKINSONISM & RELATED DISORDERS
- Diabetes is associated with postural instability and gait difficulty in Parkinson disease
- (2013) Vikas Kotagal et al. PARKINSONISM & RELATED DISORDERS
- Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
- (2013) Jose A. Santiago et al. PLoS One
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- -Synuclein in Parkinson's Disease
- (2013) L. Stefanis Cold Spring Harbor Perspectives in Medicine
- Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
- (2013) J. Michael Gaziano et al. Journal of the American Heart Association
- Parkinson's disease, insulin resistance and novel agents of neuroprotection
- (2012) Iciar Aviles-Olmos et al. BRAIN
- Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
- (2012) Jing Wang et al. Cell Stem Cell
- Risk of Parkinson Disease Onset in Patients With Diabetes: A 9-year population-based cohort study with age and sex stratifications
- (2012) Y. Sun et al. DIABETES CARE
- Effect of Bromocriptine-QR on Glycemic Control in Subjects with Uncontrolled Hyperglycemia on One or Two Oral Anti-Diabetes Agents
- (2012) Aaron Vinik et al. Endocrine Practice
- DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption
- (2012) Noppamas Pipatpiboon et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Metabolic markers or conditions preceding Parkinson's disease: A case-control study
- (2012) Rodolfo Savica et al. MOVEMENT DISORDERS
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
- (2012) Judith A. Potashkin et al. PLoS One
- Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes
- (2012) Deepak Jain et al. Journal of Molecular Cell Biology
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis
- (2011) E. Cereda et al. DIABETES CARE
- Diabetes and the Risk of Developing Parkinson's Disease in Denmark
- (2011) E. Schernhammer et al. DIABETES CARE
- Diabetes and Risk of Parkinson's Disease
- (2011) Q. Xu et al. DIABETES CARE
- Insulin resistance impairs nigrostriatal dopamine function
- (2011) J.K. Morris et al. EXPERIMENTAL NEUROLOGY
- Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in Parkinsonian brains
- (2011) Yulin Deng et al. JOURNAL OF NEURAL TRANSMISSION
- Obesity, diabetes, and risk of Parkinson's disease
- (2011) Natalia Palacios et al. MOVEMENT DISORDERS
- The role of mitochondria in insulin resistance and type 2 diabetes mellitus
- (2011) Julia Szendroedi et al. Nature Reviews Endocrinology
- Correction: MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus
- (2011) Dwi Setyowati Karolina et al. PLoS One
- Mitochondrial Dynamics in Diabetes
- (2010) Yisang Yoon et al. ANTIOXIDANTS & REDOX SIGNALING
- Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy
- (2010) Jianxin Lu et al. CLINICAL BIOCHEMISTRY
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
- (2010) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- AMP-activated protein kinase is activated in Parkinson’s disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- (2009) Jae-Sun Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
- (2009) Sehee Kim et al. JOURNAL OF ENDOCRINOLOGY
- Mitochondrial haplogroups associated with Japanese centenarians, Alzheimer's patients, Parkinson's patients, type 2 diabetic patients and healthy non-obese young males
- (2009) Shigeru Takasaki Journal of Genetics and Genomics
- Diabetes preceding Parkinson's disease onset. A case–control study
- (2009) Marco D'Amelio et al. PARKINSONISM & RELATED DISORDERS
- Risk of stroke in patients with idiopathic Parkinson disease
- (2009) Claudia Becker et al. PARKINSONISM & RELATED DISORDERS
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human cerebral neuropathology of Type 2 diabetes mellitus
- (2008) Peter T. Nelson et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
- (2008) L P Quinn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diabetes in Patients With Idiopathic Parkinson's Disease
- (2008) C. Becker et al. DIABETES CARE
- Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
- (2008) J. A. Driver et al. DIABETES CARE
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Genetics of iron regulation and the possible role of iron in Parkinson's disease
- (2008) Shannon L. Rhodes et al. NEUROBIOLOGY OF DISEASE
- Neuroinflammation in Parkinson's Disease: Is there sufficient evidence for mechanism-based interventional therapy?
- (2007) Malu et al. Frontiers in Bioscience-Landmark
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search